Browsing Tags

Disco Pharmaceuticals

AbbVie Strikes $2.54 Billion Deal with Germany’s Disco Pharmaceuticals for Cancer Therapies

US pharmaceutical giant AbbVie has agreed to invest up to $2.54 billion in a partnership with Germany-based biotechnology company Disco Pharmaceuticals to develop next-generation cancer treatments. The deal focuses on developing bispecific antibody therapies...